Menssana Research has developed the world's most sensitive breathalyzers, which are a billion times more sensitive than a breathalyzer for alcohol. Menssana's breath tests for breast cancer, lung cancer, and pulmonary tuberculosis have CE Mark for use in the EU and several other countries. Clinical studies are in progress to obtain FDA approval.
BreathX is a personal breath testing system that can be used in the home or a clinic. Breath samples are collected into ultra-clean collection bags that are sent to our laboratory for analysis with GC/SAW. The BreathX system accurately identifies women with breast cancer. It has CE marking and is currently being validated in a large U.S. multicenter study and in Scotland.
Please visit the Menssana Research Publications Archive for clinical studies of our breath tests that have been published in scientific journals: